| Paul Harry Keares, | |
|
2251 Eastern Blvd, York, PA 17402-2917 | |
| (717) 840-2730 | |
| Not Available |
| Full Name | Paul Harry Keares |
|---|---|
| Gender | Male |
| Speciality | Licensed Practical Nurse |
| Location | 2251 Eastern Blvd, York, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265994768 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | PN268300 (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paul Harry Keares, 2251 Eastern Blvd, York, PA 17402-2917 Ph: () - | Paul Harry Keares, 2251 Eastern Blvd, York, PA 17402-2917 Ph: (717) 840-2730 |
News Archive
SQI Diagnostics Inc., a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, announced today it has raised gross proceeds of CDN $2.333 million through the second tranche of a non-brokered private placement of 1,333,428 units priced at $1.75 per Unit.
The Affordable Care Act includes laws to help the public know the nutritional value of the food they buy. Consequently, larger chain restaurants will be required to indicate the calories count next to items on their menus. However, a study published yesterday suggests that this may not be the best way to encourage healthier eating habits.
A new study used mathematical modeling to explore the benefits and risks of closing down the schools to prevent new cases and the possibility of absenteeism among health care workers because they need to care for their children at home and the ultimate effect of the step on reducing the risk of deaths due to COVID-19.
Genomic Health, Inc. today announced worldwide commercial availability of its Oncotype DX® colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease. The 12-gene advanced diagnostic test is clinically validated to predict individual recurrence risk in stage II colon cancer patients following surgery, as reported at the 2009 American Society of Clinical Oncology (ASCO) meeting.
› Verified 1 days ago
Danielle J Brenneman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 Fax: 717-840-2740 | |
Ms. Christine Falu, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 | |
Emylee Aleah Waterman, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 Fax: 717-840-2741 | |
Tammy Daugherty, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2740 Fax: 717-840-2740 | |
Susan Kaye Grimek, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2740 | |
Jan Marie Kaufhold, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2251 Eastern Blvd, York, PA 17402 Phone: 717-840-2730 |